2011
DOI: 10.1111/j.1525-1403.2011.00372.x
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Outcomes of Spinal Cord Stimulation With Paddle Leads in the Treatment of Complex Regional Pain Syndrome and Failed Back Surgery Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
102
0
5

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 114 publications
(114 citation statements)
references
References 40 publications
7
102
0
5
Order By: Relevance
“…The causal factor of hardware-related complications is not well established in the literature, and further investigation is needed on the long-term efficacy of SCS implantation. 6 In this series, 40% of revisions were among patients with FBSS, and this is consistent with the previous report by Sears et al 20 There were 30 patients (21%) with axial back pain and 111 patients (79%) with neuropathic pain. Among patients with axial back pain, 50% of cases required revision.…”
Section: Revision Timelinesupporting
confidence: 81%
See 1 more Smart Citation
“…The causal factor of hardware-related complications is not well established in the literature, and further investigation is needed on the long-term efficacy of SCS implantation. 6 In this series, 40% of revisions were among patients with FBSS, and this is consistent with the previous report by Sears et al 20 There were 30 patients (21%) with axial back pain and 111 patients (79%) with neuropathic pain. Among patients with axial back pain, 50% of cases required revision.…”
Section: Revision Timelinesupporting
confidence: 81%
“…6,20 Because we performed paddle lead SCS implantation after confirming the efficacy with percutaneous SCS implantation, it is difficult to compare the efficacy and complications of these 2 types of hardware. However, an earlier report 1 showed that the overall (> 5 years) reoperation rate was approximately 3 times higher in percutaneous lead SCS implantation (22.9% vs 8.5%).…”
Section: Revision Timelinementioning
confidence: 99%
“…Se seleccionaron 22 estudios (Figura 1), de los cuales 11 fueron ensayos clínicos (8 ensayos clínicos aleatorizados y 3 ensayos clínicos no controlados) y 11 informes de casos (5,10,14,15,(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34).…”
Section: Resultados Y Discusiónunclassified
“…In terms of the neuropathic pain etiology, SCS has been applied in the treatment of deafferentation pain, central pain, phantom limb pain (PLP), causalgia, myelopathy, oncologic pain, lumbosacral fibrosis, postherpetic neuralgia (PHN), FBSS, CRPS, reflex sympathetic dystrophy (RSD), spinal cord, brainstem or brain injury, and others (3,(13)(14)(15)22,32,33,38,42,43,(46)(47)(48)(49)(50)(51)(52)(53)(54)(55)(56)(57).…”
Section: Results In Pain Managementmentioning
confidence: 99%
“…During the selection, different factors have been considered, such as the etiology of pain, type and localization of pain, age of the patient, and the radiological and neurological findings summarized in Table 1 (20)(21)(22)28,30,31,(37)(38)(39)(40)(41)(42)(43)(44).…”
Section: Selection Of Patientsmentioning
confidence: 99%